Purixan

CHEBI:CHEBI_752048

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1536490
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20251231
route
ORAL
active_ingredient_name
MERCAPTOPURINE
unii
E7WED276I5
pharm_class
Nucleoside Metabolic Inhibitor [EPC]
dosage_form
SUSPENSION
active_ingredient_strength
20 mg/mL
marketing_start_date
20140428
package_marketing_start_date
20140428
generic_name
Purixan
brand_name
PURIXAN
brand_name_base
PURIXAN
product_ndc
62484-0020
application_number
NDA205919
labeler_name
Nova Laboratories, Ltd
manufacturer_name
Nova Laboratories, Ltd
spl_id
4a9cfd5d-ab40-4cca-9c2e-39afb776e056
package_ndc
62484-0020-2
package_description
1 BOTTLE in 1 CARTON (62484-0020-2) / 100 mL in 1 BOTTLE (62484-0020-1)
spl_set_id
9fd27952-7787-47d9-b6cf-7af2dc38217b
upc
0362484002025
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class